Purple Biotech (PPBT) F-1/ARegistration statement (foreign) (amended)

Filed: 10 Mar 20, 8:13am

Exhibit 21.1

Kitov Pharma Ltd.

The following table sets forth the name and jurisdiction of incorporation of our subsidiaries as of the date hereof.

Name of Subsidiary			Jurisdiction of Incorporation

Tyrnovo Ltd.			Israel
Kitov USA Inc.			Delaware
FameWave Ltd.			Israel

Notes:

During the third quarter of 2019, we established a new wholly owned subsidiary in the USA, Kitov USA Inc. The new subsidiary did not begin operations yet.

On April 25, 2017, the boards of directors of each of Kitov Pharma Ltd. and its wholly owned subsidiary, Kitov Pharmaceuticals Ltd., approved a merger between the two entities, with Kitov Pharma Ltd. remaining as the surviving entity. The merger was completed in December 2017. Kitov Pharmaceuticals Ltd. was dissolved upon the merger, and Kitov Pharma Ltd. remained as the surviving entity. For more information on the merger, see Item 4.C – Organizational Structure in the Annual Report for 2018 on Form 20-F.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.